Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02305381

Public ClinicalTrials.gov record NCT02305381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide once weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02305381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
397 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2014 (Actual)
Primary completion
Nov 21, 2015 (Actual)
Completion
Nov 21, 2015 (Actual)
Last update posted
Jun 11, 2019

2014 – 2015

United States locations

U.S. sites
72
U.S. states
27
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Phoenix Arizona 85018 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Lomita California 90717 —
Novo Nordisk Investigational Site Los Angeles California 90057-3550 —
Novo Nordisk Investigational Site Northridge California 91325 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Riverside California 92506 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Van Nuys California 91405 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Fleming Island Florida 32003 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Port Charlotte Florida 33952 —
Novo Nordisk Investigational Site Spring Hill Florida 34609 —
Novo Nordisk Investigational Site Tampa Florida 33634 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Gillespie Illinois 62033 —
Novo Nordisk Investigational Site Skokie Illinois 60077 —
Novo Nordisk Investigational Site Avon Indiana 46123 —
Novo Nordisk Investigational Site Greenfield Indiana 46140 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Muncie Indiana 47304 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site Overland Park Kansas 66209 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site Metairie Louisiana 70002 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Waltham Massachusetts 02453 —
Novo Nordisk Investigational Site Ann Arbor Michigan 48106 —
Novo Nordisk Investigational Site Flint Michigan 48532 —
Novo Nordisk Investigational Site Kalamazoo Michigan 49009 —
Novo Nordisk Investigational Site Jackson Mississippi 39209 —
Novo Nordisk Investigational Site Las Vegas Nevada 89103 —
Novo Nordisk Investigational Site Las Vegas Nevada 89128 —
Novo Nordisk Investigational Site Teaneck New Jersey 07666 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87102 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Cincinnati Ohio 45246 —
Novo Nordisk Investigational Site Cincinnati Ohio 45255 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Kettering Ohio 45429 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73162-4704 —
Novo Nordisk Investigational Site Yukon Oklahoma 73099 —
Novo Nordisk Investigational Site Levittown Pennsylvania 19056-2404 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Athens Tennessee 37303 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Fort Worth Texas 76132 —
Novo Nordisk Investigational Site Houston Texas 77008 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Katy Texas 77450 —
Novo Nordisk Investigational Site Mesquite Texas 75149 —
Novo Nordisk Investigational Site San Antonio Texas 78224 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Sugar Land Texas 77479 —
Novo Nordisk Investigational Site Bountiful Utah 84010 —
Novo Nordisk Investigational Site Richmond Virginia 23219 —
Novo Nordisk Investigational Site Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02305381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2019 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02305381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →